EFFECT OF SCALING ON SERUM hsCRP LEVELS AND PERIODONTAL PARAMETERS IN SYSTEMICALLY HEALTHY YOUNG WOMEN WITH GINGIVITIS
1 other identifier
interventional
60
1 country
2
Brief Summary
Gingivitis is a highly prevalent chronic bacterial disease in susceptible children, adults and the elderly, persisting for decades in subjects, and is an essential precursor of periodontitis. Several studies have shown periodontitis and subgingival P. gingivalis to be associated with increased C-reactive protein (CRP) levels and CRP has been implicated as a possible mediator of the association between periodontitis and several systemic diseases Limited data are available today addressing detrimental systemic effects of experimental or natural gingivitis as they have been rarely investigated. Results of various studies support the concept that gingivitis leads to systemic inflammation and that the level of systemic inflammatory markers increases proportionately with increase in gingival inflammation. It has also been seen that appropriate dental prophylaxis can also limit systemic markers of inflammation in subjects with natural gingivitis. Sex hormones have long been considered to play an influential role on periodontal tissues, bone turnover rate, wound healing and periodontal disease progression and can influence the cellular proliferation, differentiation and growth of keratinocytes and fibroblasts. Estrogen is mainly responsible for alterations in blood vessels and progesterone stimulates the production of inflammatory mediators. In addition, some micro-organisms found in the human mouth synthesize enzymes needed for steroid synthesis and catabolism. Sex hormones are neither necessary nor sufficient to produce gingival changes by themselves. However, they may alter periodontal tissue responses to microbial plaque and thus indirectly contribute to periodontal disease. (Markou). Till date, no study has been conducted assessing the serum hsCRP levels in females of reproductive age group with gingivitis. This study, thus, aims to assess the effect of scaling on serum hsCRP levels and periodontal parameters in systemically healthy women of reproductive age group with gingivitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedDecember 6, 2022
November 1, 2022
8 months
November 26, 2022
November 26, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
bleeding on probing
bleeding on probing will be measured on 6 sites per tooth in all the teeth
6 months
gingival index
gingival index will be measured on 4 sites per tooth in all the teeth
6 months
plaque index
plaque index will be measured on 4 sites per tooth in all the teeth
6 months
serum high sensitivity c reactive protein
serum high sensitivity C reactive protein will be measured at baseline and at 6 months
6 months
Study Arms (2)
systemically healthy females with gingivitis
EXPERIMENTALscaling will be done at baseline
systemically and periodontally healthy females
NO INTERVENTIONdata will be recorded at baseline and no intervention will be done
Interventions
SCALING WILL BE DONE AT BASELINE IN TEST GROUP.
Eligibility Criteria
You may qualify if:
- females of reproductive age group (18-40 yrs)
- BMI (18.5 - 24.9)
- presence of ≥20 natural teeth
- Healthy periodontium (for control group) defined as bleeding on probing at \< 10% of sites, with pockets ≤3 mm, no probing attachment loss and no radiologic bone loss.
- Gingivitis (17) (for test group) Gingivitis (intact periodontium) is defined as bleeding on probing at ≥ 10% of sites, with pockets ≤3 mm, no probing attachment loss and no radiologic bone loss.
- Gingivitis (reduced periodontium) is defined as bleeding on probing at ≥ 10% of sites with pockets ≤3 mm with possible probing attachment loss and possible radiologic bone loss.
- Localized gingivitis is defined as 10-30% of bleeding sites. Generalized gingivitis is defined as more than 30% of bleeding sites.
You may not qualify if:
- history of androgen-secreting tumors, congenital adrenal hyperplasia and thyroid dysfunction
- nephrotic syndrome, chronic renal failure, significant cardiovascular disease, established type 1 or type 2 diabetes mellitus, active cancer within the last past 5 years
- smokers and alcoholics
- history of systemic antibiotics or oral contraceptives usage within last 3 months
- periapical pathology or oral inflammatory conditions other than gingivitis.
- any periodontal treatment within 6 months prior to study Patients with pockets ≥ 3 mm and probing attachment loss shall be excluded, hence, radiographic examination will not be needed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Post Graduate Institute of Dental Sciences
Rohtak, Haryana, 124001, India
Shikha Tewari
Rohtak, Haryana, 124001, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richa Verma, BDS
Post Graduate Institute of Dental Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2022
First Posted
December 6, 2022
Study Start
December 1, 2022
Primary Completion
July 31, 2023
Study Completion
July 31, 2023
Last Updated
December 6, 2022
Record last verified: 2022-11